X
Clive Dix: Rebuilding UK biotech
https://pharmaphorum.com/views-and-analysis/clive-dix-rebuilding-uk-biotech/
UK biotech
Gene sequencing upstart Oxford Nanopore raises another $140m
Gene sequencing upstart Oxford Nanopore raises another $140m in its bid to enable the analysis of “any living thing, by anyone, anywhere.”
Acacia Pharma stock market launch to support nausea products
Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange
